US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  
Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
9/4/2014 | published by: Kalorama Information
... proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on ...  |  read more...
USD 4,200
Companion Diagnostics Market
8/8/2014 | published by: Kalorama Information
... with several of them part of a routine diagnostic and treatment plan. This report tracks these developments and provides detailed examples of drug-test pairs.  It also provides market estimation and forecast models for business planning. ...  |  read more...
USD 3,995
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) – Global Forecast to 2023
9/10/2014 | published by: MarketsandMarkets
... diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest share of the human microbiome market in the ...  |  read more...
USD 4,650
POCT Market in China : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
... is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the ...  |  read more...
USD 2,500
Autoimmune Disease Diagnostics: Global Markets
9/1/2014 | published by: BCC Research
... 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019. This report provides: An overview of the global market for autoimmune disease diagnostics. Analyses of global market trends, ...  |  read more...
USD 6,650
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
7/1/2014 | published by: CHI Insight Pharma Reports
... development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there are many techniques used to track neurodegenerative disease progression, this report will ...  |  read more...
USD 2,495
Biomarkers in Alzheimer's Disease
8/1/2014 | published by: CHI Insight Pharma Reports
... Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the ...  |  read more...
USD 699
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024
6/25/2014 | published by: Visiongain
... medicines? Now get the latest analysis for that industry. There you explore developments (R&D), results, opportunities, trends and revenue forecasts. Visiongain’s updated report shows you what’s possible for those drugs, diagnostic tests and related technology. ...  |  read more...
USD 3,004
Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer - Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
6/26/2014 | published by: Venture Planning Group
... markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major tumor markers by country and market segment - Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for ...  |  read more...
USD 24,500
Immunodiagnostics: Spot Fast-Growing Market Segments - Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
6/26/2014 | published by: Venture Planning Group
... and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The report ...  |  read more...
USD 24,500
Biomarker Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Biomarkers in Parkinson's Disease
8/1/2014 | published by: CHI Insight Pharma Reports
... Neurodegenerative Disorders, this report focuses on the Parkinson’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing ...  |  read more...
USD 699
Biomarkers in Amyotrophic Lateral Sclerosis
8/1/2014 | published by: CHI Insight Pharma Reports
... a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With ...  |  read more...
USD 699
Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Glo
6/26/2014 | published by: MarketsandMarkets
... report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), ...  |  read more...
USD 4,650
MicroRNAs in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... with minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us ...  |  read more...
USD 6,746
Mass Spectrometry in Clinical Applications
4/29/2014 | published by: Kalorama Information
... and End User Survey , looks at the growth of Mass Spec systems being used in diagnostics and other clinical applications this year.  A Detailed Examination of the Market Opportunity for MS in Clinical Applications ...  |  read more...
USD 4,400
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)
10/16/2013 | published by: Kalorama Information
... medicine. Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease.  With them, diseases are detected earlier, more effective treatments can ...  |  read more...
USD 3,995
Biomarkers: Technologies and Global Markets
4/1/2014 | published by: BCC Research
... An overview of the global market for biomarkers. Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018. Assessments of companies poised to introduce ...  |  read more...
USD 6,650
Biomarkers
6/1/2014 | published by: RI Technologies
... Deficiencies, Hepatic, Renal, and Bone related Diseases. The market is further divided by various therapeutic areas such as - Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other for Oncology segment; Coronary Heart Diseases, ...  |  read more...
USD 4,680
MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview
4/1/2014 | published by: CHI Insight Pharma Reports
... it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding nature and ability to affect ...  |  read more...
USD 2,495
Biomarker Partnering Terms and Agreements
4/1/2014 | published by: Current Partnering
... in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to ...  |  read more...
USD 2,995
Analysis of the Western European Biomarkers Market in Drug Discovery and Development
6/13/2014 | published by: Frost & Sullivan
... were conducted with leading tier 1 and tier 2 companies and industry stakeholders, such as key clinicians, the research and development (R&D) community, heads of business development, laboratory personnel and key opinion leaders. Secondary data ...  |  read more...
USD 7,500
JAK and PI3K Signaling Pathway Markets
4/1/2014 | published by: BCC Research
... billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018. This report provides: An overview of the global market for signal transduction therapies and inhibitors ...  |  read more...
USD 6,650
Biotechnology: Circulating Tumor Cells (CTC) Technologies
4/1/2014 | published by: RI Technologies
... Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. The report serves as a guide to CTC industry, covering more than 150 companies that are engaged in CTC studies/screening, products and services. ...  |  read more...
USD 5,400
Biomarker Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
< prev 1    3  4  5  6